Stay updated on Pimavanserin Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.

Latest updates to the Pimavanserin Relapse Prevention Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new revision entry (v3.3.2) in the study record history, replacing the previous version (v3.3.1).SummaryDifference0.1%

- Check21 days agoChange DetectedNew revision entry v3.3.1 added and previous revision v3.2.0 removed from the page history, reflecting metadata updates to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe notice about government funding and NIH operating status (including updates from opm.gov) was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check43 days agoChange DetectedAn additional version entry appears in the Study Record History, while the page layout and core data remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference11%

- Check79 days agoChange DetectedUpdated the site’s version tag from v3.0.2 to v3.1.0, signaling a new release. No changes to core content, pricing, or availability are evident.SummaryDifference0.3%

Stay in the know with updates to Pimavanserin Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.